肝病变表现的肉芽肿性多血管炎
Asmita Poudel1, Prajwal Adhikari2, Vaibhav Sundaresan1
1General Internal Medicine, Northern General Hospital, Sheffield, GBR.
Cureus
|January 30, 2026
まとめ
肉芽肿性多血管炎(GPA)是一种自身免疫性血管炎,可累及肝脏。本病例报告强调了以肝脏受累和全身症状为特征的GPA的诊断挑战。
科学分野:
- 免疫学
- 风湿病学
- 消化病学
背景:
- 肉芽肿性多血管炎(GPA)是一种罕见的自身免疫性血管炎。
- 中性粒细胞与GPA的发病机制有关。
- GPA通常累及上呼吸道、肺和肾脏,但偶尔有肝脏受累的报道。
研究 の 目的:
- 介绍一例GPA伴肝脏受累的病例。
- 强调以肝脏受累为特征的GPA的诊断挑战。
主な方法:
- 病例报告。
- 回顾临床表现、实验室检查结果和诊断过程。
主要な成果:
- 一名中年男性出现全身症状和肝功能检查异常。
- 该患者最终被诊断患有累及肝脏的GPA。
結論:
- GPA的肝脏受累可能表现为全身症状和肝功能异常,且不易察觉。
- 早期识别和诊断GPA伴肝脏受累对于及时治疗和预防严重后果至关重要。
関連する概念動画
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
274
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
274
Hepatic Portal System
5.9K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.9K
Antigens Involved in Adaptive Immunity
1.4K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.4K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
243
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
243
Hepatic Drug Excretion: Influencing Factors
572
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
572
Hepatic Drug Clearance: Role of Transporters
309
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
309


